Ding S, Robek MD: Cytidine deamination and cccDNA degradation: A new approach for curing HBV? Hepatology. 2014 Dec; 2014 Oct 29. PMID: 25142126

Guayasamin RC, Reynolds TD, Wei X, Fujiwara M, Robek MD: Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. J Virol. 2014 Sep; 2014 Jul 9. PMID: 25008938

Ding S, Robek MD: Peroxisomal MAVS activates IRF1-mediated IFN-λ production. Nat Immunol. 2014 Aug. PMID: 25045870

Bolen CR, Ding S, Robek MD, Kleinstein SH: Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology. 2014 Apr; 2014 Feb 18. PMID: 23929627

van den Pol AN, Ding S, Robek MD: Long-distance interferon signaling within the brain blocks virus spread. J Virol. 2014 Apr; 2014 Jan 15. PMID: 24429359

Ding S, Khoury-Hanold W, Iwasaki A, Robek MD: Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biol. 2014 Jan; 2014 Jan 7. PMID: 24409098

Cobleigh MA, Wei X, Robek MD: A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice. J Virol. 2013 Mar; 2012 Dec 26. PMID: 23269785

Cobleigh MA, Robek MD: Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol. 2013 Jan; 2012 Nov 14. PMID: 23159948

Bolen CR, Robek MD, Brodsky L, Schulz V, Lim JK, Taylor MW, Kleinstein SH: The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. J Interferon Cytokine Res. 2013 Jan; 2012 Oct 15. PMID: 23067362

Garcia ML, Reynolds TD, Mothes W, Robek MD: Functional characterization of the putative hepatitis B virus core protein late domain using retrovirus chimeras. PLoS One. 2013; 2013 Aug 29. PMID: 24009707

Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF, Robek MD: A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology. 2011 Nov; 2011 Jun 25. PMID: 21708106

Pagliaccetti NE, Robek MD: Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus. J Interferon Cytokine Res. 2010 Aug. PMID: 20645875

Cobleigh MA, Buonocore L, Uprichard SL, Rose JK, Robek MD: A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose. J Virol. 2010 Aug; 2010 May 26. PMID: 20504927

Pagliaccetti NE, Robek MD: Interferon-λ in HCV Infection and Therapy. Viruses. 2010 Aug; 2010 Aug 5. PMID: 21994696

Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD: Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology. 2010 Jun 5; 2010 Mar 29. PMID: 20303135

Bandi P, Pagliaccetti NE, Robek MD: Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. J Interferon Cytokine Res. 2010 Mar. PMID: 20038204

Zhang Y, Lian JQ, Huang CX, Wang JP, Wei X, Nan XP, Yu HT, Jiang LL, Wang XQ, Zhuang Y, Li XH, Li Y, Wang PZ, Robek MD, Bai XF: Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. Virology. 2010 Feb 5; 2009 Nov 27. PMID: 19945134

Bandi P, Garcia ML, Booth CJ, Chisari FV, Robek MD: Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrob Agents Chemother. 2010 Feb; 2009 Nov 30. PMID: 19949053

Garcia ML, Byfield R, Robek MD: Hepatitis B virus replication and release are independent of core lysine ubiquitination. J Virol. 2009 May; 2009 Feb 25. PMID: 19244316

Pagliaccetti NE, Eduardo R, Kleinstein SH, Mu XJ, Bandi P, Robek MD: Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J Biol Chem. 2008 Oct 31; 2008 Aug 29. PMID: 18757365

Ying C, Li Y, Leung CH, Robek MD, Cheng YC: Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue. Proc Natl Acad Sci U S A. 2007 May 15; 2007 May 8. PMID: 17488817

Wollmann G, Robek MD, van den Pol AN: Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. J Virol. 2007 Feb; 2006 Nov 15. PMID: 17108037

Robek MD, Garcia ML, Boyd BS, Chisari FV: Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J Virol. 2007 Jan; 2006 Nov 1. PMID: 17079320

van den Pol AN, Robek MD, Ghosh PK, Ozduman K, Bandi P, Whim MD, Wollmann G: Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain. J Virol. 2007 Jan; 2006 Oct 25. PMID: 17065212

Ramsburg E, Publicover J, Buonocore L, Poholek A, Robek M, Palin A, Rose JK: A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J Virol. 2005 Dec. PMID: 16306575

Isogawa M, Robek MD, Furuichi Y, Chisari FV: Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005 Jun. PMID: 15890966

Robek MD, Boyd BS, Chisari FV: Lambda interferon inhibits hepatitis B and C virus replication. J Virol. 2005 Mar. PMID: 15731279

Robek MD, Boyd BS, Wieland SF, Chisari FV: Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci U S A. 2004 Feb 10; 2004 Feb 2. PMID: 14757813

Robek MD, Wieland SF, Chisari FV: Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol. 2002 Apr. PMID: 11884582